Facebook-f Twitter Linkedin Youtube
SUBSCRIBE
Facebook-f Twitter Linkedin Youtube

Allergy & Immunology CE Activities

ALLERGY & iMMUNOLOGY blog

View Details

6 Ways to Personalize Your Patient’s Asthma Treatment Plan

Asthma management is increasingly becoming more personalized. Here are 6 ways you can help personalize treatment for your patients with asthma that is severe or difficult to control.
  • Allergy & Immunology, Pulmonology
  • Blog
DOWNLOAD
View Details

Try These Diets for Your Patients with EoE

In infancy, you can see feeding problems, and as the child progresses to adulthood, you will see them complain about vomiting, abdominal pain, difficulty swallowing, food impaction, and all of this may cause them to avoid eating certain foods, eat very slowly, or avoid social situations where food is involved.
  • Allergy & Immunology
  • Blog
DOWNLOAD

RMEI Presentations

LATEST ALLERGY & IMMUNOLOGY ARTICLES

RSS Latest Allergy & Immunology Articles
  • Intention to Treat: CAR T-Cells and Safety Signals — ITT Episode 29 April 25, 2024
    This podcast episode examines CAR T-cell therapy’s early successes, broader promise, and emerging risks, as the FDA considers reports of occasional secondary cancers.
  • Brief Report: Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma April 11, 2024
    A novel CAR T-cell therapy directed at EGFRvIII with a secretable EGFR T-cell engager produced rapid responses in three patients with recurrent glioblastoma, but the responses were transient in two of the three.
    Bryan D. Choi, Elizabeth R. Gerstner, Matthew J. Frigault, Mark B. Leick, Christopher W. Mount, Leonora Balaj, Sarah Nikiforow, Bob S. Carter, William T. Curry, Kathleen Gallagher, Marcela V. Maus
  • CXCR4 Antagonist in HPV5-Associated Perianal Squamous-Cell Carcinoma April 11, 2024
    WHIM-like syndrome (warts, hypogammaglobulinemia, infections, and myelokathexis) developed in a patient with gain of CXCR4 function. Plerixafor, a CXCR4 antagonist, led to symptom reduction.
    Viviana Marin-Esteban, Lucie Molet, Marta Laganà, Dragos Ciocan, Clément Dominguez-Lafage, Nagham Alouche, Julie Nguyen, Carmen Gallego, Françoise Mercier-Nomé, Agnieszka Jaracz-Ros, Blandine Beaupain, Jérôme Bouligand, Alexis Proust, Christophe Habib, Rémy A. Bonnin, Delphine Girlich, Fanny Fouyssac, Jean-Luc Schmutz, Anne-Claire Bursztejn, Christine Bellanné-Chantelot, Emmanuelle Bourrat, Michael Herfs, Marion Espéli, Karl Balabanian, Géraldine Schlecht-Louf, Jean Donadieu, Françoise Bachelerie, Claire Deback

RMEI LIGHTNING TALKS

View Details

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.
  • Allergy & Immunology
  • 2021
View Details

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.
  • Gastroenterology
  • 2021

Previously Published CE Activities

Copyright © 2024. RMEI Medical Education, LLC. All rights reserved​

Privacy | Terms of Use